Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Vapotherm Stock (NYSE: VAPO) stock price, news, charts, stock research, profile.
Open2.800 | Close2.310 |
Vol / Avg.310.478K / 44.677K | Mkt Cap13.804M |
Day Range2.250 - 2.820 | 52 Wk Range2.250 - 23.516 |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q2 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -2.720 | -2.320 | 0.4000 | ||||
REV | 17.000M | 16.037M | -963.000K |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-02-13 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 1.00 | 0.50 |
2022-08-04 | BTIG | Marie Thibault | Downgrades | BuyNeutral | - | - | - |
2022-08-04 | Piper Sandler | Jason Bednar | Maintains | Underweight | Lowers | 2.50 | 2.00 |
2022-08-04 | William Blair | Margaret Kaczor | Downgrades | OutperformMarket Perform | - | - | - |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
VAPO | Vapotherm | -8.54% | 13.8M |
NDRA | ENDRA Life Sciences | -3.67% | 7.9M |
POAI | Predictive Oncology | 5.41% | 12.6M |
BJDX | Bluejay Diagnostics | 15.72% | 6.6M |
VERO | Venus Concept | 1.46% | 11.6M |
You can purchase shares of Vapotherm (NYSE: VAPO) through any online brokerage.
Other companies in Vapotherm’s space includes: ENDRA Life Sciences (NASDAQ:NDRA), Predictive Oncology (NASDAQ:POAI), Bluejay Diagnostics (NASDAQ:BJDX), Venus Concept (NASDAQ:VERO) and Talis Biomedical (NASDAQ:TLIS).
The latest price target for Vapotherm (NYSE: VAPO) was reported by Piper Sandler on Monday, February 13, 2023. The analyst firm set a price target for 0.50 expecting VAPO to fall to within 12 months (a possible -77.78% downside). 1 analyst firms have reported ratings in the last year.
The stock price for Vapotherm (NYSE: VAPO) is $2.2499 last updated September 25, 2023 at 7:59 PM UTC.
There is no dividend information for Vapotherm.
Vapotherm’s Q3 earnings are confirmed for Wednesday, November 1, 2023.
There is no upcoming split for Vapotherm.
Vapotherm is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.